Biodesix (BDSX)
(Delayed Data from NSDQ)
$1.80 USD
+0.01 (0.56%)
Updated Sep 12, 2024 04:00 PM ET
After-Market: $1.79 -0.01 (-0.56%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Industry / Sector Report
Industry : Medical Services
Zacks Industry Rank
Bottom 31% (173 out of 251)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.00 | 2.02 | 9.99 |
Current Quarter Estimate | -0.08 | 5.18 | 61.00 |
Year Ago Quarter Estimate | -0.12 | 1.42 | 54.84 |
Next Quarter Estimate | -0.07 | 4.83 | 63.00 |
Next Year Estimate | -0.26 | 26.00 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 41.94 | 5.70 | 15.67 |
Next Year | 27.78 | 19.00 | 11.34 |
Last 5 Years | NA | 9.60 | 8.10 |
Next 5 Years | NA | 13.40 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | 6.34 |
Price/Book (MRQ) | 7.21 | 2.01 |
Price/Cash Flow (MRFY) | NA | 13.46 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -73.09% | -12.48% |
Return on Equity (TTM) | -505.95% | -14.67% |
Debt to Equity (MRQ) | 0.99 | 30.62 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.